Get started
Author

Guillermo Castilla‐Fernández

Observed names: Castilla-Fernandez G, G. Castilla-Fernández, GUILLERMO CASTILLA FERNáNDEZ, Guillermo Castilla Fernández, Guillermo Castilla-Fernández
Institution: Bial (Portugal)
Observed institution: Bial (Portugal)
OpenAlex ID: A5092740784
Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson’s disease: pooled analysis of patient level data from two randomized open-label studies
2024 · Joaquim J. Ferreira, Jee-Young Lee, et al. · Journal of Neurology · 11
PDF
Opicapone versus entacapone: Head‐to‐head retrospective data‐based comparison of healthcare resource utilization in people with Parkinson's disease new to catechol‐O‐methyltransferase (COMT) inhibitor treatment
2023 · Glynn Harrison‐Jones, Xiaocong Li Marston, et al. · European Journal of Neurology · 11
PDF
Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial
2025 · Joaquim J. Ferreira, Olivier Rascol, et al. · European Journal of Neurology · 10
PDF
Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal seizures: post hoc analysis of a phase III trial and open-label extension study
2023 · Eugen Trinka, Rodrigo Rocamora, et al. · Therapeutic Advances in Neurological Disorders · 8
Safety and efficacy of eslicarbazepine acetate for seizure prevention in patients with stroke at high risk of developing post-stroke epilepsy: a proof-of-concept, phase 2a, randomised, double-blind, placebo-controlled antiepileptogenesis trial
2026 · Matthias J Koepp, Eugen Trinka, et al. · The Lancet Neurology · 7
Effect of zamicastat on blood pressure and heart rate response to cold pressor test: A double‐blind, randomized, placebo‐controlled study in healthy subjects
2024 · Marlene Fonseca, Cheila Ribeiro, et al. · British Journal of Clinical Pharmacology · 3
PDF
Long‐term effects of adjunctive eslicarbazepine acetate in adult Asian patients with refractory focal seizures: Post hoc analysis of a phase III trial
2024 · Sang Kun Lee, Sang Ahm Lee, et al. · Clinical and Translational Science · 3
Opicapone as Add-on to Levodopa in Parkinson's Patients without Motor Complications: Preliminary Data from EPSILON
2024 · J.J. Ferreira, O. Rascol, et al. · Parkinsonism & Related Disorders · 2
Challenges of Pain in Parkinson's Disease: Results from the OCEAN Study
2026 · Kallol Ray Chaudhuri, Joaquim J. Ferreira, et al. · Movement Disorders · 1
Correction: Opicapone for the treatment of early wearing-off in levodopa-treated Parkinson’s disease: pooled analysis of patient level data from two randomized open-label studies
2025 · Joaquim J. Ferreira, Jee-Young Lee, et al. · Journal of Neurology
PDF
Opicapone as First-Line Strategy for the Treatment of Wearing-off in Patients with Parkinson's Disease
2025 · J.J. Ferreira, J. Lee, et al. · Parkinsonism & Related Disorders
Opicapone as First-line Strategy for the Treatment of Wearing-off in Patients with Parkinson’s Disease (P7-5.026)
2025 · Joaquim Ferreira, Jee-Young Lee, et al. · Neurology
Long-term Follow-up of Opicapone Use as Add-on to Levodopa in Parkinson’s Patients Without Motor Fluctuations: Findings from the EPSILON Study (P7-5.027)
2025 · Joaquim Ferreira, Olivier Rascol, et al. · Neurology
20548. Experiencia Con Opicapona En Vida Real En Fluctuaciones Motoras Tempranas: Análisis a 3 Meses Del Estudio Reonpark
2024 · L. López Manzanares, J. García Caldentey, et al. · Neurology Perspectives
Opicapone as First-Line Strategy for the Treatment of Wearing-off in Patients with Parkinson's Disease
2024 · J.J. Ferreira, J.Y. Lee, et al. · Parkinsonism & Related Disorders
Profile of Glucocerebrosidase 1 (GCASE) activity and Glucosylsphingosine levels in GBA-PD, PD patients and healthy volunteers
2024 · N. Pires, B. Igreja, et al. · Parkinsonism & Related Disorders
HR/MS-based lipidome analysis of rat brain modulated by tolcapone
2024 · Joana Rebouta, Luísa Dória, et al. · Journal of Pharmaceutical and Biomedical Analysis
Safety and tolerability of adjunctive eslicarbazepine acetate in adolescents with focal-onset seizures: Data from three double-blind, placebo-controlled randomized clinical studies
2021 · Juan-José García-Peñas, Fábio Ikedo, et al. · Journal of the Neurological Sciences
Phase 1 Study to Investigate the Effect of P-glycoprotein Transporter Inhibition Mediated by Carvedilol on the Pharmacokinetics of Zamicastat
2021 · LUIS MAGALHAES, ANDREIA GUIMARAES, et al. · CHEST Journal
PDF
Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal-onset seizures: Post-hoc analysis from a phase III, randomized, double-blind study and a 2-year open-label extension ESL study (4565)
2021 · Eugen Trinka, Rodrigo Rocamora, et al. · Neurology
Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial
· Ferreira JJ, Rascol O, et al. · Newcastle University ePrints (Newcastle Univesity)
PDF
Works count: 21
Citation count: 54
H-index: 5
I10-index: 2
Year
Topic
Type